JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB303479

Recombinant Human GSDMB protein

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human GSDMB protein is a Human Full Length protein, expressed in HEK 293T cells, suitable for SDS-PAGE.

View Alternative Names

GSDML, PP4052, PRO2521, GSDMB, Gasdermin-B, Gasdermin-like protein

1 Images
SDS-PAGE - Recombinant Human GSDMB protein (AB303479)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human GSDMB protein (AB303479)

SDS-PAGE analysis of ab303479 using Coomassie blue staining. The protein was produced from HEK293T cells transfected with a GSDMB cDNA clone using a plasmid DNA transfection reagent.

Key facts

Purity

undefined SDS-PAGE

Expression system

HEK 293T cells

Tags

Myc-DDK tag C-Terminus

Applications

SDS-PAGE

applications

Biologically active

No

Accession

Q8TAX9

Animal free

Yes

Carrier free

No

Species

Human

Storage buffer

pH: 7.3 Constituents: 10% Glycerol (glycerin, glycerine), 0.751% Glycine, 0.394% Tris HCl

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Sequence info

[{"sequence":"MFSVFEEITRIVVKEMDAGGDMIAVRSLVDADRFRCFHLVGEKRTFFGCRHYTTGLTLMDILDTDGDKWLDELDSGLQGQKAEFQILDNVDSTGELIVRLPKEITISGSFQGFHHQKIKISENRISQQYLATLENRKLKRELPFSFRSINTRENLYLVTETLETVKEETLKSDRQYKFWSQISQGHLSYKHKGQREVTIPPNRVLSYRVKQLVFPNKETMNIHFRGKTKSFPEEKDGASSCLGKSLGSEDSRNMKEKLEDMESVLKDLTEEKRKDVLNSLAKCLGKEDIRQDLEQRVSEVLISGELHMEDPDKPLLSSLFNAAGVLVEARAKAILDFLDALLELSEEQQFVAEALEKGTLPLLKDQVKSVMEQNWDELASSPPDMDYDPEARILCALYVVVSILLELAEGPTSVSSTRTRPLEQKLISEEDLAANDILDYKDDDDKV","proteinLength":"Full Length","predictedMolecularWeight":"47.2 kDa","actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Recombinant","expressionSystem":"HEK 293T cells","accessionNumber":"Q8TAX9","tags":[{"tag":"Myc-DDK","terminus":"C-Terminus"}]}]

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GSDMB also known as Gasdermin-B is a protein that plays a significant role in cellular mechanisms. With a molecular weight of approximately 52 kDa GSDMB is encoded by the GSDMB gene. This protein belongs to the gasdermin family and is expressed in various tissues including the stomach esophagus and gastrointestinal tract. Its expression pattern suggests it might have specialized roles in these particular tissues.
Biological function summary

Gasdermin-B is involved in cell death processes particularly in pyroptosis which is a form of programmed cell death. GSDMB forms oligomeric complexes that create pores in the lipid bilayer of cellular membranes. These pores lead to cell swelling and lysis contributing to the inflammatory response. GSDMB also interacts with other gasdermin family proteins indicating a collaborative role in controlling cell death and inflammation.

Pathways

GSDMB is an important component of the pyroptosis pathway and the regulation of immune responses. It interacts with specific members of the caspase family especially Caspase-1 which activates Gasdermin-D in a similar pathway. GSDMB modulates inflammatory signaling by assisting in the release of pro-inflammatory cytokines through its pore-forming activity linking GSDMB to processes that maintain homeostasis and immune defense.

Gasdermin-B has been linked to various inflammatory and autoimmune conditions such as Crohn's disease and ulcerative colitis. Altered expression levels of GSDMB can influence disease severity and progression. Additionally GSDMB interacts with TNF-alpha a cytokine involved in the immune response highlighting its importance in inflammatory disease environments. Exploring GSDMB's role in these conditions can advance therapeutic strategies for treating such disorders.

Specifications

Form

Liquid

Additional notes

> 80% as determined by SDS-PAGE and Coomassie blue staining

General info

Function

Gasdermin-B. Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death (PubMed : 32299851). This form constitutes the precursor of the pore-forming protein : upon cleavage, the released N-terminal moiety (Gasdermin-B, N-terminal) binds to membranes and forms pores, triggering pyroptosis (PubMed : 32299851). Also acts as a regulator of epithelial cell repair independently of programmed cell death : translocates to the plasma membrane and promotes epithelial maintenance and repair by regulating PTK2/FAK-mediated phosphorylation of PDGFA (PubMed : 35021065).. Gasdermin-B, N-terminal. Pore-forming protein produced by cleavage by granzyme A (GZMA), which causes membrane permeabilization and pyroptosis in target cells of cytotoxic T and natural killer (NK) cells (PubMed : 27281216, PubMed : 32299851). Key downstream mediator of granzyme-mediated cell death : (1) granzyme A (GZMA), delivered to target cells from cytotoxic T- and NK-cells, (2) specifically cleaves Gasdermin-B to generate this form (PubMed : 32299851). After cleavage, moves to the plasma membrane, homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis (PubMed : 32299851, PubMed : 36599845, PubMed : 36991122, PubMed : 36991125). The different isoforms recognize and bind different phospholipids on membranes, promoting cell death of different target cells (PubMed : 34022140, PubMed : 36157507, PubMed : 36991122, PubMed : 36991125).. Isoform 4. Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and mediates pyroptosis (PubMed : 28154144, PubMed : 36157507, PubMed : 36899106, PubMed : 36991122, PubMed : 36991125). Following cleavage and activation by granzyme A (GZMA), the N-terminal part binds to membrane inner leaflet lipids, homooligomerizes within the human plasma membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis (PubMed : 28154144, PubMed : 36157507, PubMed : 36899106, PubMed : 36991122, PubMed : 36991125). Recognizes and binds membrane inner leaflet lipids of human cells, such as phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate, and more weakly to phosphatidic acid (PubMed : 28154144, PubMed : 36157507). Also binds sufatide, a component of the apical membrane of epithelial cells (PubMed : 28154144).. Isoform 6. Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and mediates pyroptosis of human cells (PubMed : 36899106, PubMed : 36991122, PubMed : 36991125). Following cleavage and activation by granzyme A (GZMA), the N-terminal part binds to membrane inner leaflet lipids, homooligomerizes within the human plasma membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis (PubMed : 36899106, PubMed : 36991122, PubMed : 36991125).. Isoform 1. Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and specifically mediates cell death of Gram-negative bacteria in response to infection (PubMed : 34022140). Following cleavage and activation by granzyme A (GZMA), the N-terminal part recognizes and binds phospholipids found on Gram-negative bacterial membranes, such as lipid A and cariolipin, homooligomerizes within the bacterial membranes and forms pores, triggering pyroptosis followed by cell death (PubMed : 34022140). In contrast to isoform 4, does not bind to membrane inner leaflet lipids of host human cell, such as phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate (PubMed : 34022140).. Isoform 2. Not able to trigger pyroptosis.. Isoform 3. Not able to trigger pyroptosis.

Sequence similarities

Belongs to the gasdermin family.

Post-translational modifications

Cleavage by granzyme A (GZMA) relieves autoinhibition by releasing the N-terminal moiety (Gasdermin-B, N-terminal) that initiates pyroptosis (PubMed:32299851, PubMed:34022140, PubMed:36157507, PubMed:36899106, PubMed:36991125). Not cleaved by other granzymes (PubMed:32299851). Major cleavage site takes places after Lys-244; a minor cleavage site takes place after Lys-229 (PubMed:32299851). Cleavage by neutrophil elastase ELANE, inhibits its ability to trigger pyroptosis (PubMed:36899106).. Palmitoylated.. (Microbial infection) Ubiquitinated by S.flexneri IpaH7.8, leading to its degradation by the proteasome, thereby preventing its ability to form pores in bacterial-derived membranes.

Product protocols

Target data

Gasdermin-B. Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death (PubMed : 32299851). This form constitutes the precursor of the pore-forming protein : upon cleavage, the released N-terminal moiety (Gasdermin-B, N-terminal) binds to membranes and forms pores, triggering pyroptosis (PubMed : 32299851). Also acts as a regulator of epithelial cell repair independently of programmed cell death : translocates to the plasma membrane and promotes epithelial maintenance and repair by regulating PTK2/FAK-mediated phosphorylation of PDGFA (PubMed : 35021065).. Gasdermin-B, N-terminal. Pore-forming protein produced by cleavage by granzyme A (GZMA), which causes membrane permeabilization and pyroptosis in target cells of cytotoxic T and natural killer (NK) cells (PubMed : 27281216, PubMed : 32299851). Key downstream mediator of granzyme-mediated cell death : (1) granzyme A (GZMA), delivered to target cells from cytotoxic T- and NK-cells, (2) specifically cleaves Gasdermin-B to generate this form (PubMed : 32299851). After cleavage, moves to the plasma membrane, homooligomerizes within the membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis (PubMed : 32299851, PubMed : 36599845, PubMed : 36991122, PubMed : 36991125). The different isoforms recognize and bind different phospholipids on membranes, promoting cell death of different target cells (PubMed : 34022140, PubMed : 36157507, PubMed : 36991122, PubMed : 36991125).. Isoform 4. Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and mediates pyroptosis (PubMed : 28154144, PubMed : 36157507, PubMed : 36899106, PubMed : 36991122, PubMed : 36991125). Following cleavage and activation by granzyme A (GZMA), the N-terminal part binds to membrane inner leaflet lipids, homooligomerizes within the human plasma membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis (PubMed : 28154144, PubMed : 36157507, PubMed : 36899106, PubMed : 36991122, PubMed : 36991125). Recognizes and binds membrane inner leaflet lipids of human cells, such as phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate, and more weakly to phosphatidic acid (PubMed : 28154144, PubMed : 36157507). Also binds sufatide, a component of the apical membrane of epithelial cells (PubMed : 28154144).. Isoform 6. Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and mediates pyroptosis of human cells (PubMed : 36899106, PubMed : 36991122, PubMed : 36991125). Following cleavage and activation by granzyme A (GZMA), the N-terminal part binds to membrane inner leaflet lipids, homooligomerizes within the human plasma membrane and forms pores of 10-15 nanometers (nm) of inner diameter, triggering pyroptosis (PubMed : 36899106, PubMed : 36991122, PubMed : 36991125).. Isoform 1. Precursor of a pore-forming protein that acts as a downstream mediator of granzyme-mediated cell death and specifically mediates cell death of Gram-negative bacteria in response to infection (PubMed : 34022140). Following cleavage and activation by granzyme A (GZMA), the N-terminal part recognizes and binds phospholipids found on Gram-negative bacterial membranes, such as lipid A and cariolipin, homooligomerizes within the bacterial membranes and forms pores, triggering pyroptosis followed by cell death (PubMed : 34022140). In contrast to isoform 4, does not bind to membrane inner leaflet lipids of host human cell, such as phosphatidylinositol 4-phosphate, phosphatidylinositol 5-phosphate, bisphosphorylated phosphatidylinositols, such as phosphatidylinositol (4,5)-bisphosphate (PubMed : 34022140).. Isoform 2. Not able to trigger pyroptosis.. Isoform 3. Not able to trigger pyroptosis.
See full target information GSDMB

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com